Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2026-01-02 @ 12:06 AM
Study NCT ID:
NCT04739358
Status:
TERMINATED
Last Update Posted:
2023-10-18
First Post:
2021-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC
Sponsor:
Criterium, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
01AT21-MET
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |